216 related articles for article (PubMed ID: 24400116)
21. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.
Yuan L; Zhao N; Wang J; Liu Y; Meng L; Guo S; Wiemer EAC; Chen Q; Mao Y; Ben J; Ma J
Theranostics; 2021; 11(15):7247-7261. PubMed ID: 34158848
[No Abstract] [Full Text] [Related]
22. ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.
Zhu T; Zhao Y; Zhang J; Li L; Zou L; Yao Y; Xu Y
Int J Oncol; 2011 Feb; 38(2):419-26. PubMed ID: 21132268
[TBL] [Abstract][Full Text] [Related]
23. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
[TBL] [Abstract][Full Text] [Related]
24. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
25. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
26. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
27. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
[TBL] [Abstract][Full Text] [Related]
28. MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts.
Yamashita T; Kobayashi Y; Mizoguchi T; Yamaki M; Miura T; Tanaka S; Udagawa N; Takahashi N
Biochem Biophys Res Commun; 2008 Jan; 365(2):252-7. PubMed ID: 17983595
[TBL] [Abstract][Full Text] [Related]
29. Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.
Wang T; Liu Q; Zhou L; Yuan JB; Lin X; Zeng R; Liang X; Zhao J; Xu J
Int J Mol Sci; 2015 Nov; 16(11):27470-81. PubMed ID: 26593901
[TBL] [Abstract][Full Text] [Related]
30. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
31. p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2.
Schonhoff CM; Park SW; Webster CR; Anwer MS
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G999-G1005. PubMed ID: 27012769
[TBL] [Abstract][Full Text] [Related]
32. Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6.
Guma M; Hammaker D; Topolewski K; Corr M; Boyle DL; Karin M; Firestein GS
Arthritis Rheum; 2012 Sep; 64(9):2887-95. PubMed ID: 22488549
[TBL] [Abstract][Full Text] [Related]
33. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
[TBL] [Abstract][Full Text] [Related]
34. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis.
Tanaka N; Kamanaka M; Enslen H; Dong C; Wysk M; Davis RJ; Flavell RA
EMBO Rep; 2002 Aug; 3(8):785-91. PubMed ID: 12151339
[TBL] [Abstract][Full Text] [Related]
35. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
36. AMPKα1 negatively regulates osteoclastogenesis and mitigates pathological bone loss.
Ribeiro MSP; Venturini LGR; Speck-Hernandez CA; Alabarse PVG; Xavier T; Taira TM; Duffles LF; Cunha FQ; Fukada SY
J Biol Chem; 2023 Dec; 299(12):105379. PubMed ID: 37871745
[TBL] [Abstract][Full Text] [Related]
37. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
38. Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus.
Jin Y; Fan Y; Yan EZ; Liu Z; Zong ZH; Qi ZM
Acta Pharmacol Sin; 2006 Oct; 27(10):1309-16. PubMed ID: 17007737
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis.
Inoue T; Boyle DL; Corr M; Hammaker D; Davis RJ; Flavell RA; Firestein GS
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5484-9. PubMed ID: 16567640
[TBL] [Abstract][Full Text] [Related]
40. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
